New study reveals molecular mechanism in Alzheimer’s disease

A research team at the Institute of Neurosciences of the University of Barcelona (UBneuro) has led a study describing a new molecular mechanism that affects RNA processing and alters the process of protein synthesis in the brains of Alzheimer’s patients.

AbbVie’s Pharmacyclics files patent suit against BeiGene over BTK rival Brukinsa

Pharmacyclics is bringing its BTK battle to court. The AbbVie unit filed suit against BeiGene on Tuesday, alleging the company’s competing blood cancer drug Brukinsa

June 17, 2023

New AI approach enhances cardiovascular risk assessment

Risk calculators are used to evaluate disease risk for millions of patients, making their accuracy crucial.

September 24, 2024

FDA adcomm votes in favor of Geron’s anemia drug for cancer patients despite questions on risk

Members of the FDA’s Oncologic Drugs Advisory Committee voted 12 to 2 on Thursday that the benefits of Geron’s imetelstat outweigh safety risks for the

March 15, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.